These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 8607489

  • 1. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.
    Bertoni G, Sassatelli R, Nigrisoli E, Tansini P, Bianchi G, Della Casa G, Bagni A, Bedogni G.
    Am J Gastroenterol; 1996 Feb; 91(2):258-63. PubMed ID: 8607489
    [Abstract] [Full Text] [Related]

  • 2. Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease.
    Vcev A, Vceva A, Takac B, Dmitrović B, Stimac D, Stimac T, Kovac D, Pezerović D, Blazanović A, Ivandić A, Karner I.
    Acta Med Croatica; 1998 Feb; 52(4-5):209-14. PubMed ID: 9988898
    [Abstract] [Full Text] [Related]

  • 3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 4. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
    Trevisani L, Sartori S, Caselli M, Ruina M, Verdianelli G, Abbasciano V.
    Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
    [Abstract] [Full Text] [Related]

  • 5. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M, Viver JM, Esteve M, Fernández-Bañares F, Lite J, Espinós JC, Quintana S, Salas A, Garau J.
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [Abstract] [Full Text] [Related]

  • 6. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L, Suchower L, Frantz J, Connors A, Neil G.
    Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G, Schwery S, Giezendanner S, Flury R, Wüst J, Meyenberger C, Wirth HP.
    Schweiz Med Wochenschr; 1996 Feb 03; 126(5):153-8. PubMed ID: 8685685
    [Abstract] [Full Text] [Related]

  • 8. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
    Schütze K, Hentschel E, Hirschl AM.
    Hepatogastroenterology; 1999 Feb 03; 46(28):2358-62. PubMed ID: 10521998
    [Abstract] [Full Text] [Related]

  • 9. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M, Massarrat S, Zare S, Fattahi M, Javan A, Etaati H, Dehbashi N.
    Am J Gastroenterol; 1995 Sep 03; 90(9):1419-23. PubMed ID: 7661161
    [Abstract] [Full Text] [Related]

  • 10. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F, Moum B, Haug JB, Tolås P, Breder O, Aubert E, Høie O, Søberg T, Flaaten B, Farup P, Berge T.
    Am J Gastroenterol; 1997 Feb 03; 92(2):248-53. PubMed ID: 9040200
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
    Gisbert JP, Mur M, Boixeda D, Ceña G, Martín de Argila C, Alvarez Baleriola I, Abraira V, García Plaza A.
    Med Clin (Barc); 1997 Apr 12; 108(14):524-9. PubMed ID: 9190436
    [Abstract] [Full Text] [Related]

  • 15. Azithromycin for the cure of Helicobacter pylori infection.
    Di Mario F, Dal Bó N, Grassi SA, Rugge M, Cassaro M, Donisi PM, Vianello F, Kusstatscher S, Salandin S, Grasso GA, Ferrana M, Battaglia G.
    Am J Gastroenterol; 1996 Feb 12; 91(2):264-7. PubMed ID: 8607490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 18. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J, Stolte M, Peitz U, Tillenburg B, Köhl H, Becker T, Börsch G.
    Z Gastroenterol; 1995 Oct 26; 33(10):590-3. PubMed ID: 7502551
    [Abstract] [Full Text] [Related]

  • 19. [Omeprazole and azithromycin with and without metronidazole in the eradication of Helicobacter pylori in duodenal ulcer disease].
    Vcev A, Vceva A, Ivandić A, Mihaljević S, Micunović N, Dmitrović B, Vuković D, Takac B, Gardasanić J, Horonitz M, Karner I.
    Lijec Vjesn; 1997 Jul 26; 119(7):210-3. PubMed ID: 9471481
    [Abstract] [Full Text] [Related]

  • 20. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC, van Zwet AA, Moolenaar W, Wolfhagen MJ, ten Bokkel Huinink J.
    Am J Gastroenterol; 1996 Jan 26; 91(1):93-7. PubMed ID: 8561152
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.